Medtronic wins FDA nod for oxygenation device; Bacterin's CEO to resign;

 @FierceMedDev: Seventh Sense revs up crucial trial for microneedle blood collector. More | Follow @FierceMedDev

 @MarkHFierce: The NYT has come out against not just a device tax repeal, but industry lobbying efforts to make their case. Story | Follow @MarkHFierce

 @DamianFierce: AbioMed is studying a next-gen Impella pump targeting FDA approval. Article |& Follow @DamianFierce

> Medtronic ($MDT) snagged FDA clearance for its Affinity Fusion device, a next-generation oxygenation system for cardiac surgery. Release

> Welch Allyn launched a new FlexiPort EcoCuff, a single-patient-use blood pressure cuff the company says can both cut down on hospital-borne contamination and environmental impacts. More

> California's NuvoLase won a CE mark for its PinPointe FootLaser, designed to treat nail fungus. News

> Kimberly-Clark Health Care bought device maker Life Tech's ($LIFE) anesthesia business for an undisclosed amount. Item

> The Korea Food and Drug Administration changed its name to the Ministry of Food and Drug Safety as part of a regulatory reorganization that will affect both device and drug companies doing business there. Blog

> Many multiple sclerosis patients had hoped an implantable balloon treatment for the condition might succeed where drugs have failed, but a rigorous test of the method found no significant benefit. Article

> Bacterin International's president and CEO Guy Cook said he will resign, though he'll stay on in the interim as the board looks for a successor. Story

> SafeStitch Medical raised $3 million in a private placement that will fund development of disposable devices for minimally invasive gastroenterology procedures. Story

Biotech News

 @FierceBiotech: Karolinska portfolio biotech Axelar says PhII lung cancer drug on promising track. More | Follow @FierceBiotech

 @JohnCFierce: Clavis' Olav Hellebo says co. could be sold or shut down, but it's all down to liquidation value now. More | Follow @JohnCFierce

 @RyanMFierce: Immunomedics won an $18M settlement from BoA, now it could use an R&D win with those cancer programs. WSJ Article | Follow @RyanMFierce

> Obama seeks revolutionary brain discoveries on a budget. Story

> Analysis: No quick fix in sight for AstraZeneca's PhIII woes. More

> PolyMedix defaults and hands over a PhII antibiotic to bankruptcy court. News

Pharma News

 @FiercePharma: Lilly works up $180M addition to Indy insulin mfring + $80M in other projects. PR hints at city tax incentives: Release | Follow @FiercePharma

 @EricPFierce: Recalls by Hospira encourage other players to jump into sterile injectable drug manufacturing. More | Follow @EricPFierce

> Merz swoops into Obagi deal with $385M bid, topping Valeant. More

> AZ's Pulmicort patent loss could cost $100M-plus. Story

Biotech Research News

 @EmilyMFierce: Waiting for details today on Obama's $100M brain mapping project. Background here: Story | Follow @EmilyMFierce

> More evidence found for new anti-cancer agent. More

> Diabetes drug slows aging process in worms. Report

> Researchers launch consortium to study neurodegenerative diseases. Item

> Dutch researchers detect early Parkinson's pathology. Article

> New drug could combat resistant malaria strains. More

Pharma Manufacturing News

> Manufacturing issues still dog A.P. Pharma. Story

> Japan's Asada Milling gets warning letter. More

> Lilly doubles down on insulin plant, expands API capacity. Article

> Sanofi adding manufacturing capacity in China, Vietnam. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.